Background {#Sec1}
==========

Individuals with posttraumatic stress disorder (PTSD) report high levels of dissatisfaction across multiple life domains including physical health \[[@CR1]\] and social and occupational functioning \[[@CR2]\]. It is generally assumed that evidence-based interventions for PTSD, if effective, should also lead to broader improvements in life satisfaction \[[@CR3]\].

Evidence suggests that self-rated quality of life in those with PTSD improves in tandem with symptom improvement during psychological \[[@CR3]\] and pharmacological \[[@CR4]\] treatment. However, many of these studies focused on health-related quality of life (e.g., physical and mental health quality of life as assessed by measures such as the Short Form Health Survey \[[@CR5]\]). Notwithstanding the overlap with symptom measures, a reliance on disability-focused measures may have perpetuated an assumption that quality of life and wellbeing are synonymous with the absence of impairment. There thus remains a need for a more comprehensive assessment of quality of life in relation to PTSD treatment if the full benefits of PTSD treatment are to be adequately understood.

Personal wellbeing refers to the subjective dimension of quality of life \[[@CR6]\]. In addition to the physical and mental health domains of quality of life, the notion of personal wellbeing captures a broader range of dimensions including perceptions of one's standard of living, life achievement, quality of personal relationships, perceived safety, community engagement and future security \[[@CR6]\]. Furthermore, the concept of personal wellbeing incorporates the possibility that an individual might thrive rather than simply lack disability.

Overall life satisfaction is a similar concept to that of personal wellbeing and appears to be relatively low in individuals with PTSD \[[@CR7]\]. However, there remains a relative absence of research that has used measures capturing a broad range of domains of personal wellbeing in treatment people receiving treatment for PTSD (such as relationship satisfaction, perceived safety, etc). For instance, the few studies that have investigated changes in either life satisfaction or personal wellbeing during PTSD treatment, have typically focused only on one specific domain, such as spiritual wellbeing (e.g., \[[@CR8]\]). An exception was a treatment trial of venlafaxine versus sertraline in addition to psychotherapy for refugees with PTSD, which reported small to medium-size improvements in wellbeing from pre to posttreatment, but did not include a follow-up assessment to determine whether the benefits persisted \[[@CR9]\]. Investigation of whether improvements in perceived wellbeing persist is important for ensuring that changes in perceived wellbeing are reliable and remain once individuals complete treatment programs and return to their home environments.

Improving our understanding of these processes has the potential to provide a deeper understanding of the broader benefits of PTSD treatment beyond symptoms alone. For example, even though there is increasing evidence to suggest that symptomatic improvement persists following treatment, it remains unclear whether this also applies for any improvements in personal wellbeing. There are various pathways by which psychological therapies could affect changes in wellbeing, one being an increased sense of self-efficacy that might arise from strategies that promote mastery over one's symptoms.

The purpose of the present study was to investigate whether a four-week residential group treatment program for PTSD is associated with improvements in personal wellbeing in addition to symptoms of PTSD. Consistent with findings regarding the similar but distinct concept of quality of life \[[@CR3]\], we hypothesized that improvements in personal wellbeing would improve in tandem with improvements in PTSD symptoms. We also wanted to determine to what extent changes in other core overlapping symptom domains (such as anxiety and depression) were associated with overall personal wellbeing. The program includes a 3- and 9-month review of client progress, with the 9-month assessment point being the final scheduled follow-up appointment and the primary endpoint of the present study.

Method {#Sec2}
======

One hundred and twenty-four participants (Mean age = 45.5 years, *SD* = 10.3; 19.4% female \[*n* = 24\]) were recruited from an inpatient residential PTSD treatment program between July 2009 and October 2015. All participants had a primary diagnosis of PTSD according to the Clinician Administered PTSD Scale for DSM-IV (CAPS; \[[@CR10]\]). Individuals with a current substance use disorder identified either at interview or from the Alcohol Use Identification Test (AUDIT; \[[@CR11]\]) are excluded from the treatment program. The study was approved by the St John of God Health Care Human Research Ethics Committee (ref 839).

Treatment {#Sec3}
---------

All participants were attending their first four-week residential group-based treatment program for PTSD. The majority of group participants were funded to attend the program through worker's compensation claims (57.9% who were mostly former emergency services workers), by the Department of Veteran's Affairs (27.8%) or the by Australian Defence Force (7.9%), with only a small minority supported through private health insurance (6.3%).

The group program (five days per week for four weeks) included the following components: (i) psychoeducation about PTSD, (ii) arousal reduction strategies, (iii) cognitive restructuring, (iv) exploration of trauma themes such as safety, trust, and power/control consistent with cognitive processing therapy interventions \[[@CR12]\] and (v) discharge planning. Concurrent with the group intervention, participants also attended individual therapy sessions twice a week where prolonged imaginal exposure therapy was conducted. The program included a 3- and 9-month review of client progress.

Measures {#Sec4}
--------

The following self-report measures were administered.

The 42-item version of the Depression Anxiety Stress Scales (DASS-42; \[[@CR13]\]) was administered. The DASS-42 have been shown to have good internal consistency (Cronbach α's ranging from 0.89 to 0.96; \[[@CR14]\]), strong convergent and discriminant validity \[[@CR15]\], as well as favorable test-retest reliability \[[@CR14]\].

The Posttraumatic Stress Disorder Checklist for DSM-IV Civilian version (PCL; \[[@CR16]\]) was used to assess PTSD symptoms. The PCL is a 17-item measure of current PTSD symptoms. It is strongly correlated with interview-based measures of PTSD, is able to effectively discriminate those with and without a PTSD diagnosis \[[@CR16]\] and appears to have sound internal consistency and test-retest reliability \[[@CR17]\]. The internal consistency (Cronbach's α) for the PCL in the present sample was 0.91.

The Personal Wellbeing Index (PWI) is a 7-item scale \[[@CR6]\]. The items include standard of living, personal health, life achievement, personal relationships, personal safety, community connectedness and future security. It has an eighth item pertaining to satisfaction with one's spirituality or religion; however, completion of this item is optional, thus total scores for the present study were derived from summing the first seven items. Each item is rated on a 10-point scale ranging from "No satisfaction at all" (0) to "Completely satisfied" (10), such that higher scores reflect greater levels of personal wellbeing. The scale has sound convergent validity with similar measures of wellbeing \[[@CR18]\]. The mean score on the PWI in a large Australian community sample was 75.3 (for the 7-item version; \[[@CR19]\]). The internal consistency (Cronbach's α) for the PWI in the present sample was 0.84.

Other self-report measures are routinely administered as part of an accreditation process for the program. However, these measures were not relevant to the current research question and so are not reported here.

Data analysis {#Sec5}
-------------

Descriptive statistics (frequency, means, and standard deviation) were calculated for all key variables using SPSS 24.0. Repeated measures ANOVAs withpost-hoc pairwise t-test comparisons (using a Bonferrroni adjustment) were used to determine which variables changed significantly across time.

Generalized Estimating Equations (GEE) were used to determine which variables predicted PWI total score. The GEE approach allows estimation of regression coefficients that reflect the longitudinal relation between a predictor variable and an outcome variable \[[@CR20]\]. In contrast to linear mixed model approaches, the GEE approach makes fewer assumptions about the data. For instance, the GEE approach depends only on correct specification of the mean of the outcome (given the covariates), not necessarily on the joint distribution of both observed data and random effects (as a linear mixed model approach does; \[[@CR21]\]). The GEE approach also allows inference at the population rather than individual level. Gender was included as a factor and age, PCL total score, and DASS Depression, Anxiety and Stress subscales included as covariates. Gender was included on the basis that women with PTSD report different trauma histories to those experienced by men and given that PTSD appears to impact the quality of life of women in potentially different ways \[[@CR22]\]. Age was included on the basis that some domains of wellbeing, such as perceptions of life achievement, could conceivably be related to age. In accordance with the recommendations of Twisk \[[@CR20]\], we ran GEE models both with and without time point in the model, but we discuss findings for the model that includes time given that time point can potentially confound the relation between time-dependent covariates and PWI score.

Goodness of fit tests are not available for GEE analyses; however, comparison of the Quasi likelihood under Independence model Criterion (QIC) values were compared for three correlation structures: unstructured, exchangeable and AR(1), with AR(1) providing the lowest value (29,938.36). Thus, results for the exchangeable correlation structure are presented.

Results {#Sec6}
=======

Data were available for *N* = 124 at the start of treatment; *n* = 115 (91.9%) participants at the end of residential treatment and for *n* = 80 (64.5%) at the 9-month follow-up. Participants who did and did not complete the posttreatment and 9-month follow-up questionnaires did not differ significantly on any demographic variable or on pretreatment PCL, DASS Anxiety, DASS Stress or PWI scores. DASS Depression scores were an exception, with lower pretreatment DASS Depression scores for those with complete pretreatment data at posttreatment (Means = 22.0 \[SD = 9.6\] vs 30.9 \[SD = 7.2); *t* = 2.85, *df* = 122, *p* = 0.005) and 9-month follow-up (Means = 20.9 \[SD = 9.47\] vs 26.07 \[SD = 9.47\]; *t* = 2.92, *df* = 122, *p* = 0.004) respectively.

Pretreatment mean PWI total scores (27.85) were well below the mean of the broader Australian community (75.3 for the 7-item version; *t* = 48.3, *df* = 123, *p* \< 0.001; \[[@CR19]\]) indicating lower overall perceived personal wellbeing.

There was a significant main effect of change in PWI scores across the nine months although the magnitude of improvement was small (*F* (3, 228) = 5.11, *p* = 0.002, η~p~^2^ = 0.06). The only significant pairwise comparison indicated an improvement in PWI scores from pre to posttreatment (from a mean of 27.85 to 32.27; *p* \< 0.0001).

Table [1](#Tab1){ref-type="table"} summarizes the scores on other key questionnaires at pretreatment, posttreatment, 3-month and 9-month follow-up. There were significant main effects for DASS Depression (*F*(3, 219) = 12.45, *p* \< 0.0001), DASS Stress (*F*(3, 216) = 11.27, *p* \< 0.0001) and PCL (*F*(3, 222) = 9.40, *p* \< 0.0001) scores. The significant decrease in PCL scores from pre to posttreatment indicates that the active phase of treatment was beneficial in reducing PTSD symptoms (from a mean of 62.78 to 56.93; *p* \< 0.0001). However, across the follow-up period, from posttreatment to 3-month and 9-month follow-ups respectively, PCL scores remained consistent and did not appear to change further from posttreatment levels (all pairwise *p*'s \> 0.05). The DASS Depression and Stress subscale scores also improved from pretreatment to posttreatment (from a mean of 20.66 to 16.12, *p* \< 0.0001 and 26.71 to 21.26, *p* \< 0.0001 for DASS Depression and Stress respectively). However, both DASS Depression and DASS Stress scores *increased* from posttreatment to the 3-month (from a mean of 16.12 to 21.14, *p* \< 0.0001 for DASS depression; 21.26 to 25.62, *p* \< 0.0001 for DASS Stress) and 9-month follow-ups respectively (from a mean of 16,12 to 21.93, *p* \< 0.001 for DASS Depression; 21.26 to 25.96, *p* \< 0.0001 for DASS Stress). There were no significant changes in DASS Anxiety scores across the nine months of the study and all pairwise comparisons were not significant.Table 1Means (SD) for symptom measures and perceived wellbeing at pretreatment, posttreatment, 3-month and 9-month follow-up(a) Pretreatment(b) Posttreatment(c) 3-month follow-up(d) 9-month follow-upPairwise significant differences^a^Mean (*SD*)Mean (*SD*)Mean (*SD*)Mean (*SD*)DASS 21 -- Depression20.66 (9.48)16.12 (9.42)21.14 (10.24)21.93 (10.08)a \> b, b \< c, b \< dDASS 21 -- Anxiety17.00 (8.42)15.78 (8.22)16.75 (8.09)17.16 (8.65)nsDASS 21 -- Stress26.71 (9.38)21.26 (8.83)25.62 (8.43)25.96 (7.98)a \> b, b \< c, b \< dPCL62.78 (11.59)56.93 (11.66)56.50 (12.77)57.31 (11.72)a \> b, a \> c, a \> dPWI27.85 (11.70)32.27 (11.12)29.88 (11.92)30.49 (12.43)a \< b*DASS 21* Depression and anxiety stress scales -- 21 items, *PCL* Posttraumatic Stress Disorder Checklist for DSM-IV Civilian version^a^Different subscripts correspond to *p* \< 0.05 following Bonferroni pairwise corrections for post-hoc comparisons

Generalised estimating equations (GEE) analyses {#Sec7}
-----------------------------------------------

The results of the GEE analyses are summarized in Table [2](#Tab2){ref-type="table"}. PCL total scores, DASS Depression, and age were each significant predictors of PWI scores. Decreases in PCL total and DASS depression were significant predictors of increased (improved) PWI scores as well as (older) age. When controlling for other variables, time point was not a significant predictor of PWI scores. We note that the overall pattern of results was the same when timepoint was (Table [2](#Tab2){ref-type="table"}) and was not included in the model (Additional file [1](#MOESM1){ref-type="media"}: Table S1) supporting the role of assessed change in other variables as accounting for the observed change in PWI scores.Table 2Generalized Estimating Equations (GEE) results (*N* = 124)95% Wald confidence interval*B*Std ErrorLowerUpperIntercept45.903.6038.8552.94PCL total−0.260.05−0.37− 0.16DASS Depression−0.390.08−0.53− 0.24DASS Anxiety−0.060.10−0.260.13DASS Stress−0.040.08−0.200.12Age0.190.060.070.30Timepoint 4 (9mth follow-up)1.001.06−1.083.09Timepoint 3 (3mth follow-up)−0.331.03−2.341.70Timepoint 2 (posttreatment)−0.270.95−2.131.59Timepoint 1 (Index: pretreatment)0Gender (Male)−0.812.36−5.423.81Gender (Index: Female)0*DASS* Depression and Anxiety Stress scales, *PCL* Posttraumatic symptom checklist for DSM-IVA greater PWI score reflects a greater level of personal wellbeing

Given that there is some degree of overlap between two of the items of the PWI (pertaining to perceived safety and future security) and PTSD symptoms, we re-ran the analyses after excluding these items, noting that the internal consistency of the PWI remained high at 0.77, 0.82 & 0.87 at pretreatment, posttreatment and 9-month follow-up, respectively. The overall pattern of results for the GEE analysis was the same in that changes in PCL, DASS-Depression and age each independently predicted changes in PWI scores.

Discussion {#Sec8}
==========

There are three key findings from the present study. First, individuals seeking treatment for PTSD reported low levels of personal wellbeing. This finding is consistent with reports of low levels of life satisfaction among individuals with PTSD \[[@CR23]\]. There are also broad parallels with findings from studies of similar constructs in PTSD, such as self-reported health-related quality of life, which have indicated perceived impairments which go beyond psychological symptoms themselves.

Second, there were significant improvements in PWI scores across the 9-months of the study, although these were only small in magnitude and did not remain significant once changes in other variables (such as PTSD symptoms) were accounted for. This relative persistence of low levels of perceived personal wellbeing may be due to the broad range of challenges faced by participants in our sample who were in many cases transitioning from military and emergency services careers to distinctly different roles. These transitions may impact one's perceptions of standard of living, life achievement and community connectedness \[[@CR24], [@CR25]\], none of which were an explicit focus of the treatment program. Other studies that have investigated the benefits of interventions to boost social connectedness and awareness of positive emotions indicate that personal wellbeing may improve when these are explicit aims for treatment \[[@CR25]\].

Third, our results also suggest that improved perceived personal wellbeing is associated with older age, and improvements in PTSD and depressive symptoms. This is consistent with findings regarding the similar construct of quality of life \[[@CR26]\]. Given that both depression and PTSD are thought to be characterised in part by distorted cognitions about the self, the world and the future \[[@CR27], [@CR28]\], it is not surprising that improvement in depression and PTSD symptoms might be associated with changes in perceived personal wellbeing. For instance, depressed individuals have been demonstrated to hold a pervasive and general negative outlook with a tendency to attribute negative events to stable, internal and global factors \[[@CR29]\] which could conceivably influence their ratings of personal wellbeing.

The personal wellbeing of individuals seeking treatment for PTSD may possibly be improved in either of two ways. First, our results suggest that improvements in symptoms of depression and PTSD may independently lead to improvements in wellbeing, albeit, to a small extent. This holds particular promise in the case of depression. As noted, in the present study, depression symptoms intensified preceding the 3 month and 9 month follow-ups: If specific interventions could preempt these setbacks then there may also be associated benefits for personal wellbeing. Second, to the extent that the treatment program focused on improvements in PTSD symptoms, there remains the possibility that additional improvements in personal wellbeing may be achieved by including approaches from personal wellbeing therapy \[[@CR30]\], or other adjunctive interventions.

The implications of these current findings need to be considered in light of the study's limitations. Improvement in PTSD symptoms was not a focus of the present study and the overall symptom-focused outcomes of the treatment program have been reported elsewhere \[[@CR31]\]. Nonetheless, the relatively small clinical magnitude of improvement in PTSD symptoms is noteworthy and may be reflective of the complexity of clients who attended the program in that most had previously not benefitted from treatment in other services. Alternatively, it may indicate that subset of participants did not receive a full course of exposure-based therapy in their individual sessions. Unfortunately, we lack the data to determine if this was the case. We relied on a single measure of personal wellbeing, albeit one that has been validated in the Australian community and has sound psychometric properties. It may be that measures of Quality of Life across multiple life domains would detect improvements related to more specific areas of daily living. We were also not able to quantify the extent to which the residential treatment program targeted perceptions of personal wellbeing as opposed to PTSD symptoms. The relatively high rate of program participants supported by funding (workers compensation schemes, Department of Veterans' Affairs and Department of Defence) and the high rate of follow-up attrition (64% of the sample attending the 9-month follow-up) suggests that the findings may not generalize to other studies and settings, although we believe it is reflective of the routine setting in which the study was conducted. Finally, our study did not include a control group or randomized allocation to treatment and control conditions precluding causal inferences about the role of treatment in changes in personal wellbeing.

Conclusions {#Sec9}
===========

Extending the benefits of PTSD treatments beyond a narrow focus on symptomatic improvement is important for helping individuals with PTSD to enhance their lives. The present results highlight how levels of personal wellbeing are typically low in individuals with PTSD and may only improve to a small extent during and following an intensive residential trauma-focused treatment program. Further research should consider the most effective pathways for enhancing personal wellbeing, whether these be by improving symptoms or through approaches that have a separate focus.

Additional file
===============

 {#Sec10}

Additional file 1:Table 1. Generalized Estimating Equations (GEE) results without time as a predictor (*N* = 124). (DOCX 13 kb)

AR

:   Auto Regressive Order

CBT

:   Cognitive Behavioural Therapy

DASS-42

:   Depression Anxiety Stress Scales -- 42 item version

GEE

:   Generalised Estimating Eqs.

PCL

:   Posttraumatic Stress Disorder Checklist

PTSD

:   Posttraumatic Stress Disorder

PWI

:   Personal Wellbeing Index

QIC

:   Quasi likelihood under Independence model Criterion
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